Position
SIMPLEX TRADING, LLC in Aclaris Therapeutics, Inc.
Back to the book · All holders of ACRS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $8.3K$3.01 → $3.75
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 16.7K | $50.2K | — | — | — | 0.0% |
| Q1 2026 | 11.2K | $42.1K | $3.75 | $8.3K | −$16.4K | 0.0% |